Zero ad trackers.We never sell your data.

Home / For clinicians / Conditions / Rheumatology

Rheumatology: rare disease drugs and conditions

Not a doctor or health care professional? This page is for clinicians.Go to the patient version

1 condition and 1 prescribing guide so far.

By specialty and condition

Each condition page compares its drugs side by side and lists FDA decisions, label changes and open trials.

Rheumatology
Dermatomyositis
1 prescribing guide · 3 other approved medicines listed
Compare the drugs →
Lisraya brepocitinib

Prescribing guides

The first 90 days from the prescriber's side, built from the current label, the drugmaker's program and one public insurer policy.

Dermatomyositis
Lisraya (brepocitinib)TB Screening, Labs, Vaccines and PANo REMS; consider TB evaluation (the boxed warning says test before and during), hepatitis screening, CBC, hepatic and renal function, pregnancy status and immunization update including zoster before day 1; avoid initiation with ANC below 1,000, ALC below 500, Hb below 8g/dL, active hepatitis B or C or an active serious infection; prescription and My Compass Support enrollment routed to Orsini or PANTHERx.Label August 27, 2026 · checked November 9, 2026